KN-93 Phosphate

CAS No. 1188890-41-6

KN-93 Phosphate( —— )

Catalog No. M17179 CAS No. 1188890-41-6

KN-93 Phosphate is a potent and specific CaMKII inhibitor (Ki: 0.37 μM), no inhibitory for PKC, APK, MLCK or Ca2+-PDE activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 49 In Stock
10MG 127 In Stock
25MG 241 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    KN-93 Phosphate
  • Note
    Research use only, not for human use.
  • Brief Description
    KN-93 Phosphate is a potent and specific CaMKII inhibitor (Ki: 0.37 μM), no inhibitory for PKC, APK, MLCK or Ca2+-PDE activities.
  • Description
    KN-93 Phosphate is a potent and specific CaMKII inhibitor (Ki: 0.37 μM), no inhibitory for PKC, APK, MLCK or Ca2+-PDE activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CaMKII
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    1188890-41-6
  • Formula Weight
    599.03
  • Molecular Formula
    C26H29ClN2O4S·H3PO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN(C/C=C/c1ccc(cc1)Cl)Cc1ccccc1N(CCO)S(=O)(=O)c1ccc(cc1)OC.OP(=O)(O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sumi M, et al. Biochem Biophys Res Commun. 1991, 181(3), 968-975.
molnova catalog
related products
  • FM04

    FM04 is an orally active and highly potent inhibitor of P-glycoprotein (P-gp) with an EC50 value of 83 nM. FM04 can interact with Q1193 and I1115 in human P-gp nucleotide binding domain 2 (NBD2).

  • 5-(2-Furyl)-2-hydrox...

    5-(2-Furyl)-2-hydroxybenzoic acid is an inhibitor of glycolate oxidase (GO) and can be used to study metabolism-related disorders such as primary hyperoxaluria type 1 (PH1).

  • NCGC00378430

    NCGC00378430 is a potent?SIX1/EYA2?interaction inhibitor that disrupts the SIX1/EYA2 complex, EMT, and Metastasis.